Update on the SNG001 drug, an INFbeta therapy for COVID-19

Holgate, S. T.

2020, eLearning , 1 online resource (1 streaming audio file (13 min.)).

Provided through HSTalks

4026316

Access Online

No summary currently available.

Show/hide reviews and other info

Provided by Syndetics | Terms of Use

Subjects
Subjects

Details

Full Bibliographic Record
Publication information:	London : Henry Stewart Talks, 2020.
Language:	English
Record ID:	4026316
Variant Title:	Update on the SNG001 drug, an INFβ therapy for COVID-19
Variant Title:	Update on the SNG001 drug, an Interferon-beta therapy for COVID-19
Format:	eLearning
Physical description:	1 online resource (1 streaming audio file (13 min.)).
Date acquired:	December 8, 2020
More creator details:	an interview with Stephen Holgate.
Series statement:	Research and clinical interviews,
Series title:	Henry Stewart talks. Biomedical & life sciences collection. Research and clinical interviews.
General note:	Audio interview.
General note:	Title from title frames.
Contents note:	Contents: An overview of SNG001 therapy -- Findings of the phase 2 clinical trial -- Treatment potential at different stages of the disease -- Advantages of the treatment delivery mode and accessibility -- Potential use as a prophylaxis treatment -- Follow up clinical trials to be undertaken -- Other treatment settings for INFβ.
Technical details:	Mode of access: World Wide Web.
Contributor:	Henry Stewart Talks (Firm), issuing body.
Electronic access:	Access online
Electronic access:	Series
Access URL:	https://ezproxy.torontopubliclibrary.ca/login?url=https://hstalks.com/bs/p/1060/